Cargando…
Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
BACKGROUND: Skeletal dysplasia is typically diagnosed using a combination of radiographic imaging, clinical examinations, and molecular testing. Identifying a molecular diagnosis for an individual with a skeletal dysplasia can lead to improved clinical care, guide future medical management and treat...
Autores principales: | Scocchia, Alicia, Kangas-Kontio, Tiia, Irving, Melita, Hero, Matti, Saarinen, Inka, Pelttari, Liisa, Gall, Kimberly, Valo, Satu, Huusko, Johanna M., Tallila, Jonna, Sistonen, Johanna, Koskenvuo, Juha, Alastalo, Tero-Pekka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501536/ https://www.ncbi.nlm.nih.gov/pubmed/34627339 http://dx.doi.org/10.1186/s13023-021-02025-7 |
Ejemplares similares
-
Correction to: Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
por: Scocchia, Alicia, et al.
Publicado: (2022) -
Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients
por: Hathaway, Julie, et al.
Publicado: (2021) -
Biallelic loss-of-function in NRAP is a cause of recessive dilated cardiomyopathy
por: Koskenvuo, Juha W., et al.
Publicado: (2021) -
DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy
por: Heliö, Krista, et al.
Publicado: (2020) -
Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis
por: Gall, Kimberly, et al.
Publicado: (2021)